- call +1-201-465-4211
- email sales@mrinsights.biz
In vitro fertilisation (IVF) is a process of fertilisation where an egg is combined with sperm outside the body, in vitro ("in glass"). The process involves monitoring and stimulating a woman's ovulatory process, removing an ovum or ova (egg or eggs) from the woman's ovaries and letting sperm fertilise them in a liquid in a laboratory. The fertilised egg (zygote) undergoes embryo culture for 2–6 days, and is then transferred to the same or another woman's uterus, with the intention of establishing a successful pregnancy.
Scope of the Report:
This report studies the IVF market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the IVF market by product type and applications/end industries.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for IVF in US$ by following Product Segments.: Intracytoplasmic Sperm Injection (ICSI), Frozen Embryo Replacement (FER) and Pre-implantation Genetic Diagnosis (PGD)
Company profiles are primarily based on public domain information including company
Vitrolife AB
EMD Serono Inc
Irvine scientific
Cooper Surgical Inc
Cook Medical Inc
Thermo Fisher Scientific Inc
Genea Biomedx
Auxogyn, Inc
Oxford Gene Technology
Ovascience
The global IVF market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of IVF.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Vitrolife AB
EMD Serono Inc
Irvine scientific
Cooper Surgical Inc
Cook Medical Inc
Thermo Fisher Scientific Inc
Genea Biomedx
Auxogyn, Inc
Oxford Gene Technology
Ovascience
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Intracytoplasmic Sperm Injection (ICSI)
Frozen Embryo Replacement (FER)
Pre-implantation Genetic Diagnosis (PGD)
Market Segment by Applications, can be divided into
Clone
Transgenic
Embryonic Stem Cell Isolation and Culture
Test Tube Baby
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 IVF Market Overview
1.1 Product Overview and Scope of IVF
1.2 Classification of IVF by Types
1.2.1 Global IVF Revenue Comparison by Types (2017-2023)
1.2.2 Global IVF Revenue Market Share by Types in 2017
1.2.3 Intracytoplasmic Sperm Injection (ICSI)
1.2.4 Frozen Embryo Replacement (FER)
1.2.5 Pre-implantation Genetic Diagnosis (PGD)
1.3 Global IVF Market by Application
1.3.1 Global IVF Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Clone
1.3.3 Transgenic
1.3.4 Embryonic Stem Cell Isolation and Culture
1.3.5 Test Tube Baby
1.4 Global IVF Market by Regions
1.4.1 Global IVF Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) IVF Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) IVF Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) IVF Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) IVF Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) IVF Status and Prospect (2013-2023)
1.5 Global Market Size of IVF (2013-2023)
2 Manufacturers Profiles
2.1 Vitrolife AB
2.1.1 Business Overview
2.1.2 IVF Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Vitrolife AB IVF Revenue, Gross Margin and Market Share (2016-2017)
2.2 EMD Serono Inc
2.2.1 Business Overview
2.2.2 IVF Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 EMD Serono Inc IVF Revenue, Gross Margin and Market Share (2016-2017)
2.3 Irvine scientific
2.3.1 Business Overview
2.3.2 IVF Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Irvine scientific IVF Revenue, Gross Margin and Market Share (2016-2017)
2.4 Cooper Surgical Inc
2.4.1 Business Overview
2.4.2 IVF Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Cooper Surgical Inc IVF Revenue, Gross Margin and Market Share (2016-2017)
2.5 Cook Medical Inc
2.5.1 Business Overview
2.5.2 IVF Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Cook Medical Inc IVF Revenue, Gross Margin and Market Share (2016-2017)
2.6 Thermo Fisher Scientific Inc
2.6.1 Business Overview
2.6.2 IVF Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Thermo Fisher Scientific Inc IVF Revenue, Gross Margin and Market Share (2016-2017)
2.7 Genea Biomedx
2.7.1 Business Overview
2.7.2 IVF Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Genea Biomedx IVF Revenue, Gross Margin and Market Share (2016-2017)
2.8 Auxogyn, Inc
2.8.1 Business Overview
2.8.2 IVF Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Auxogyn, Inc IVF Revenue, Gross Margin and Market Share (2016-2017)
2.9 Oxford Gene Technology
2.9.1 Business Overview
2.9.2 IVF Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Oxford Gene Technology IVF Revenue, Gross Margin and Market Share (2016-2017)
2.10 Ovascience
2.10.1 Business Overview
2.10.2 IVF Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Ovascience IVF Revenue, Gross Margin and Market Share (2016-2017)
3 Global IVF Market Competition, by Players
3.1 Global IVF Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 IVF Players Market Share
3.2.2 Top 10 IVF Players Market Share
3.3 Market Competition Trend
4 Global IVF Market Size by Regions
4.1 Global IVF Revenue and Market Share by Regions
4.2 North America IVF Revenue and Growth Rate (2013-2018)
4.3 Europe IVF Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific IVF Revenue and Growth Rate (2013-2018)
4.5 South America IVF Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa IVF Revenue and Growth Rate (2013-2018)
5 North America IVF Revenue by Countries
5.1 North America IVF Revenue by Countries (2013-2018)
5.2 USA IVF Revenue and Growth Rate (2013-2018)
5.3 Canada IVF Revenue and Growth Rate (2013-2018)
5.4 Mexico IVF Revenue and Growth Rate (2013-2018)
6 Europe IVF Revenue by Countries
6.1 Europe IVF Revenue by Countries (2013-2018)
6.2 Germany IVF Revenue and Growth Rate (2013-2018)
6.3 UK IVF Revenue and Growth Rate (2013-2018)
6.4 France IVF Revenue and Growth Rate (2013-2018)
6.5 Russia IVF Revenue and Growth Rate (2013-2018)
6.6 Italy IVF Revenue and Growth Rate (2013-2018)
7 Asia-Pacific IVF Revenue by Countries
7.1 Asia-Pacific IVF Revenue by Countries (2013-2018)
7.2 China IVF Revenue and Growth Rate (2013-2018)
7.3 Japan IVF Revenue and Growth Rate (2013-2018)
7.4 Korea IVF Revenue and Growth Rate (2013-2018)
7.5 India IVF Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia IVF Revenue and Growth Rate (2013-2018)
8 South America IVF Revenue by Countries
8.1 South America IVF Revenue by Countries (2013-2018)
8.2 Brazil IVF Revenue and Growth Rate (2013-2018)
8.3 Argentina IVF Revenue and Growth Rate (2013-2018)
8.4 Colombia IVF Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue IVF by Countries
9.1 Middle East and Africa IVF Revenue by Countries (2013-2018)
9.2 Saudi Arabia IVF Revenue and Growth Rate (2013-2018)
9.3 UAE IVF Revenue and Growth Rate (2013-2018)
9.4 Egypt IVF Revenue and Growth Rate (2013-2018)
9.5 Nigeria IVF Revenue and Growth Rate (2013-2018)
9.6 South Africa IVF Revenue and Growth Rate (2013-2018)
10 Global IVF Market Segment by Type
10.1 Global IVF Revenue and Market Share by Type (2013-2018)
10.2 Global IVF Market Forecast by Type (2018-2023)
10.3 Intracytoplasmic Sperm Injection (ICSI) Revenue Growth Rate (2013-2023)
10.4 Frozen Embryo Replacement (FER) Revenue Growth Rate (2013-2023)
10.5 Pre-implantation Genetic Diagnosis (PGD) Revenue Growth Rate (2013-2023)
11 Global IVF Market Segment by Application
11.1 Global IVF Revenue Market Share by Application (2013-2018)
11.2 IVF Market Forecast by Application (2018-2023)
11.3 Clone Revenue Growth (2013-2018)
11.4 Transgenic Revenue Growth (2013-2018)
11.5 Embryonic Stem Cell Isolation and Culture Revenue Growth (2013-2018)
11.6 Test Tube Baby Revenue Growth (2013-2018)
12 Global IVF Market Size Forecast (2018-2023)
12.1 Global IVF Market Size Forecast (2018-2023)
12.2 Global IVF Market Forecast by Regions (2018-2023)
12.3 North America IVF Revenue Market Forecast (2018-2023)
12.4 Europe IVF Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific IVF Revenue Market Forecast (2018-2023)
12.6 South America IVF Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa IVF Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure IVF Picture
Table Product Specifications of IVF
Table Global IVF and Revenue (Million USD) Market Split by Product Type
Figure Global IVF Revenue Market
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
